doi: 10.1111/dom.13340 44 WeinstockRSGuerciBUmpierrezGNauckMASkrivanekZMilicevicZ
The most common violations included continued compounding after shortage resolution (68% of letters), addition of supplemental ingredients not present in approved formulations (54%), inadequate sterility testing (31%), and marketing claims implying bioequivalence with FDA-approved products (26%)
Areas of emerging interest include opioid, nicotine, and stimulant use, though the evidence base remains very limited
It was approved by the US Food and Drug Administration (FDA) as a 2-line drug for T2DM patients in 2005, and was marketed in China in 2009
If you miss a dose, follow the specific instructions provided with your medication, which vary by agent
Animal studies have shown that it may cause fat to accumulate where it shouldnt, causing liver problems or oxidative stress